An Investigation into the Reasoning for the Ban on Fixed Dosage Combinations
Abstract
Either a single treatment or the sequential administration of multiple medications can be used to treat an aberrant situation. Utilising fixed dose combinations—specific dosage forms including two or more medications is another strategy. A fixed dose combination is a pharmacological administration method that combines two or more active ingredients into one. Because of all the benefits these products offer, prescribers and consumers alike are quite interested in using them. There are unavoidable intrinsic disadvantages as well. Popular antibiotics, pain relievers, and multivitamins are among the 156 FDC medications that the Health Ministry has prohibited over safety concerns. By outlawing certain potentially dangerous drug combinations, the government hopes to safeguard the public's health. The health concerns connected with these pharmaceuticals have led to their prohibition on production, marketing, and distribution, according to a gazette notice published by the Health Ministry on August 21, 2024. The prohibited FDCs included in the notice include antibiotics, anti-allergic drugs, painkillers, multivitamins, and fever and hypertension combo therapies. This article examines both the advantages and disadvantages of FDCs associated with the ban by the Government of India, as outlined in the gazette. The primary focus is on identifying the underlying causes for the ban.
How to Cite This Article
Tapan Kumar Mahato, Rajendra Singh Kushwaha, Saurabh Sharma, Zankhana Brahmbhatt, Ankur Patel (2024). An Investigation into the Reasoning for the Ban on Fixed Dosage Combinations . International Journal of Multidisciplinary Research and Growth Evaluation (IJMRGE), 5(5), 657-662. DOI: https://doi.org/10.54660/.IJMRGE.2024.5.5.657-662